Rituximab as a Therapeutic Strategy in Hemophagocytic Lymphohistiocytosis: Efficacy, Outcomes, and Survival-Insights From a Systematic Review.
Article in American Journal of Clinical Oncology (June 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in American Journal of Clinical Oncology (June 2024)
Article in Respirology Case Reports (May 2021)
Article in Frontiers in Oncology (January 2021)